NuGen Medical Devices Inc.
NGMD.V
TSX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 57.50% | -80.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 57.50% | -80.34% | |||
| Cost of Revenue | 53.13% | -82.42% | |||
| Gross Profit | 59.38% | -78.67% | |||
| SG&A Expenses | 44.97% | 16.96% | |||
| Depreciation & Amortization | -- | 7.83% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.65% | 10.02% | |||
| Operating Income | -20.85% | -22.60% | |||
| Income Before Tax | 19.09% | -253.54% | |||
| Income Tax Expenses | -210.00% | 11.11% | |||
| Earnings from Continuing Operations | 19.43% | -254.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 19.43% | -254.19% | |||
| EBIT | -20.85% | -22.60% | |||
| EBITDA | -24.18% | -26.01% | |||
| EPS Basic | 18.92% | -254.17% | |||
| Normalized Basic EPS | 19.57% | -253.33% | |||
| EPS Diluted | 18.92% | -254.17% | |||
| Normalized Diluted EPS | 19.57% | -253.33% | |||
| Average Basic Shares Outstanding | 0.00% | 0.25% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||